{"id":995357,"date":"2026-08-14T07:33:05","date_gmt":"2026-08-14T11:33:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/"},"modified":"2026-08-14T07:33:05","modified_gmt":"2026-08-14T11:33:05","slug":"faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/","title":{"rendered":"Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments<\/b><\/p>\n<p class=\"bwalignc\"><i>Appointments reinforce technical operations and investor engagement as the company advances its clinical programs<\/i><\/p>\n<p>AUSTIN, Texas&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nFaeth Therapeutics, Inc. (Nasdaq: FTH) today announced the appointments of Deepak Tiwari as Senior Vice President, Technical Operations, and Matt Biegler as Senior Vice President, Investor Relations, as the company prepares for upcoming PIKTOR clinical milestones.<\/p>\n<p>\nTiwari will lead Faeth\u2019s technical operations organization, overseeing chemistry, manufacturing and controls (CMC), and supply chain activities supporting the company\u2019s PIKTOR clinical development program and potential future commercialization. Biegler will lead the company\u2019s investor relations function and engagement with current and prospective investors.<\/p>\n<p>\n\u201cExpanding our leadership team is an important part of preparing Faeth for its next stage of development,\u201d said Anand Parikh, Chairman, President and Chief Executive Officer of Faeth Therapeutics. \u201cDeepak brings extensive experience in CMC, manufacturing and supply chain across the biopharmaceutical industry, while Matt brings experience spanning biotechnology equity research, clinical development strategy and the capital markets. Their appointments add capabilities directly relevant to the continued development of PIKTOR and our engagement with the investment community.\u201d<\/p>\n<p>\nTiwari brings approximately 30 years of biopharmaceutical experience spanning CMC, technical operations, manufacturing and supply chain. His background includes roles at Bayer, Baxter International, Agennix, Omthera (acquired by AstraZeneca), Particle Sciences (acquired by Lubrizol), and Sucampo Pharmaceuticals. He has also advised biopharmaceutical companies on CMC strategy and technical operations.<\/p>\n<p>\nBiegler joins Faeth from Oppenheimer &amp; Co., where he was a senior analyst covering emerging biotechnology companies. Before his Wall Street career, he spent more than five years in the healthcare industry, including in clinical research operations at Parexel International, with a focus on clinical trial design and strategy. He holds a bachelor\u2019s degree in biochemistry and molecular biology from Boston University and a master\u2019s degree in biotechnology from Columbia University.<\/p>\n<p><b>About Faeth Therapeutics<\/b><\/p>\n<p>\nFaeth Therapeutics, Inc. (Nasdaq: FTH) is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The Company\u2019s lead program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer. Faeth was co-founded in 2019 by Anand Parikh and Oliver Maddocks, Ph.D., together with scientific founders Lewis Cantley, Ph.D., the discoverer of the PI3K pathway; Siddhartha Mukherjee, M.D., D.Phil.; Karen Vousden, Ph.D.; Scott Lowe, Ph.D.; and Greg Hannon, Ph.D. The Company intends to use its website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.faeththerapeutics.com&amp;esheet=54589119&amp;newsitemid=20260814791639&amp;lan=en-US&amp;anchor=www.faeththerapeutics.com&amp;index=1&amp;md5=94e3b5a077e167e483436fc3ef614b6c\">www.faeththerapeutics.com<\/a> and follow the Company on LinkedIn.<\/p>\n<p><b>Cautionary Note Regarding Forward-Looking Statements<\/b><\/p>\n<p>\nThis press release contains \u201cforward-looking statements\u201d within the meaning of the federal securities laws, including the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts and may be identified by words such as \u201canticipate,\u201d \u201cbelieve,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201cwould,\u201d \u201ccould,\u201d \u201cshould,\u201d \u201cestimate,\u201d \u201cpotential,\u201d \u201ctarget,\u201d \u201con track\u201d and similar expressions, although not all forward-looking statements contain these words. These statements include, but are not limited to, statements regarding the company\u2019s expectations regarding its pipeline and development plans and the potential development of PIKTOR. Forward-looking statements are based on management\u2019s current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks and uncertainties include those described under the headings \u201cRisk Factors\u201d and \u201cSummary of Risk Factors\u201d in the company\u2019s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date of this press release, and the company undertakes no obligation to update any forward-looking statement, except as required by law.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260814791639r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260814791639\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260814791639\/en\/<\/a><\/span><\/p>\n<p><b>Investor Contact:<br \/>\n<\/b><br \/>Matthew Biegler, SVP, Investor Relations<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:matt@faeththerapeutics.com\">matt@faeththerapeutics.com<\/a><\/p>\n<p><b>Media Contact:<br \/>\n<\/b><br \/>Patrick Schmidt, Consort Partners<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:faeththerapeutics@consortpartners.com\">faeththerapeutics@consortpartners.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Texas United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Oncology Health General Health Research Science Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260814791639\/en\/2875717\/3\/Faeth_Therapeutics_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments Appointments reinforce technical operations and investor engagement as the company advances its clinical programs AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211; Faeth Therapeutics, Inc. (Nasdaq: FTH) today announced the appointments of Deepak Tiwari as Senior Vice President, Technical Operations, and Matt Biegler as Senior Vice President, Investor Relations, as the company prepares for upcoming PIKTOR clinical milestones. Tiwari will lead Faeth\u2019s technical operations organization, overseeing chemistry, manufacturing and controls (CMC), and supply chain activities supporting the company\u2019s PIKTOR clinical development program and potential future commercialization. Biegler will lead the company\u2019s investor relations function and engagement with current and prospective investors. \u201cExpanding our leadership team is an important part of preparing Faeth for its next stage &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-995357","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments Appointments reinforce technical operations and investor engagement as the company advances its clinical programs AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211; Faeth Therapeutics, Inc. (Nasdaq: FTH) today announced the appointments of Deepak Tiwari as Senior Vice President, Technical Operations, and Matt Biegler as Senior Vice President, Investor Relations, as the company prepares for upcoming PIKTOR clinical milestones. Tiwari will lead Faeth\u2019s technical operations organization, overseeing chemistry, manufacturing and controls (CMC), and supply chain activities supporting the company\u2019s PIKTOR clinical development program and potential future commercialization. Biegler will lead the company\u2019s investor relations function and engagement with current and prospective investors. \u201cExpanding our leadership team is an important part of preparing Faeth for its next stage &hellip; Continue reading &quot;Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-14T11:33:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260814791639r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments\",\"datePublished\":\"2026-08-14T11:33:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\\\/\"},\"wordCount\":690,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260814791639r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\\\/\",\"name\":\"Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260814791639r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-08-14T11:33:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260814791639r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260814791639r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/","og_locale":"en_US","og_type":"article","og_title":"Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments - Market Newsdesk","og_description":"Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments Appointments reinforce technical operations and investor engagement as the company advances its clinical programs AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211; Faeth Therapeutics, Inc. (Nasdaq: FTH) today announced the appointments of Deepak Tiwari as Senior Vice President, Technical Operations, and Matt Biegler as Senior Vice President, Investor Relations, as the company prepares for upcoming PIKTOR clinical milestones. Tiwari will lead Faeth\u2019s technical operations organization, overseeing chemistry, manufacturing and controls (CMC), and supply chain activities supporting the company\u2019s PIKTOR clinical development program and potential future commercialization. Biegler will lead the company\u2019s investor relations function and engagement with current and prospective investors. \u201cExpanding our leadership team is an important part of preparing Faeth for its next stage &hellip; Continue reading \"Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-14T11:33:05+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260814791639r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments","datePublished":"2026-08-14T11:33:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/"},"wordCount":690,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260814791639r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/","name":"Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260814791639r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-08-14T11:33:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260814791639r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260814791639r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/faeth-therapeutics-strengthens-executive-team-with-senior-leadership-appointments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/995357","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=995357"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/995357\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=995357"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=995357"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=995357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}